all - Opinion Summaries
Page 52 of 88
Showing Result 511 - 520 of 874
| Description | Date | Docket # |
|---|---|---|
In re: Gilead Sci. Sec. Litig.United States Ninth Circuit
Administrative Law, Civil Procedure, Corporation & Enterprise Law, Drugs & Biotech, Evidence, Securities LawIn a securities fraud action claiming defendant-biopharmaceutical company misled the investing public by representing that demand for its most popular... |
08/11/2008 | 06-16185 |
Little Gem Life Sciences LLC v. Orphan Med., Inc.United States Eighth Circuit
Civil Procedure, Corp. Governance, Corporation & Enterprise Law, Drugs & Biotech, M&A, Securities LawIn a securities class action against a company alleging that the company and two of its principal executive officers negligently failed to disclose... |
08/11/2008 | 07-3285 |
New Jersey Carpenters Pension & Annuity Funds v. Biogen IDEC, Inc.United States First Circuit
Class Actions, Drugs & Biotech, Health Law, Securities LawIn a federal securities class action matter alleging defendant drug company and senior executives intentionally misrepresented the safety of and the... |
08/07/2008 | 07-2626 |
County of San Diego v. San Diego NORMLCalifornia Court of Appeal
Constitutional Law, Drugs & Biotech, Government Law, Health LawJudgment rejecting plaintiff counties' claims that Medical Marijuana Program Act (MMP)is invalid under preemption principles and that MMP poses an... |
07/31/2008 | D050333 |
Bailey v. Janssen Pharmaceutica, Inc.United States Eleventh Circuit
Civil Procedure, Drugs & Biotech, Health Law, Injury & Tort LawIn a case of first impression involving the limitations period for removal in a multi-defendant litigation, denial of plaintiff's motion to remand her... |
07/29/2008 | 07-12258 |
Clayworth v. Pfizer, Inc.California Court of Appeal
Antitrust & Trade Regulation, Commercial Law, Drugs & BiotechIn a matter of first impression in California antitrust law, the court of appeals rules that the pass-on defense is available to defendants accused of... |
07/25/2008 | A116798 |
Meijer, Inc. v. Biovail Corp.United States DC Circuit
Administrative Law, Antitrust & Trade Regulation, Civil Procedure, Drugs & Biotech, Intellectual Property, PatentIn consolidated antitrust actions alleging that a drug manufacturer misused its patent to keep a generic equivalent to one of its drugs off the... |
07/25/2008 | 05-7066, 05-7069, 05-7084, 06-7118 |
Chein v. Drug Enforcement Admin.United States DC Circuit
Administrative Law, Drugs & Biotech, Health LawDEA's revocation of petitioner-physician's practitioner's registration and denial of his application for a registration to export Schedule III and... |
07/22/2008 | 07-1051 |
Bandana Trading Co., Inc. v. Quality Infusion Care, Inc.California Court of Appeal
Civil Procedure, Commercial Law, Contracts, Drugs & Biotech, Health LawIn an action for breach of contract, judgment for plaintiff is affirmed over claims of error that: 1) the trial court erred when it refused to remove... |
07/21/2008 | B196119 |
Eisai Co. Ltd. v. Dr. Reddy's Lab., Ltd.United States Federal Circuit
Drugs & Biotech, Intellectual Property, PatentIn a patent case involving a class of drugs known as proton pump inhibitors, summary judgment for plaintiff ruling that its patent was enforceable is... |
07/21/2008 | 2007-1397, 2007-1398 |
Results 511 to 520 of 874